United States · FDA National Drug Code directory
Mirabegron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-890_bea3fc38-dab4-4a11-b7a1-911b302f6504
- Product NDC
- 67877-890
- Form
- FOR SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- Mirabegron
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260615
- Source listing expiry
- 20271231
Source-listed ingredients
- MIRABEGRON — 8 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 CARTON (67877-890-88) / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLE · 67877-890-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →